Starting Jan. 1, New Hampshire’s Medicaid program will stop covering GLP-1 drugs — Wegovy, Zepbound, and others — for weight loss, the state Department of Health and Human Services told providers in October.

“We looked at the way that the state was supporting coverage for GLP-1 medicines and found that this was a fairly significant cost driver,” Gov. Kelly Ayotte told reporters this week. “And so we looked at the medically necessary reasons for it in terms of those who had pre-existing conditions and made the decision working with Health and Human Services to come up with a modified policy that will still allow medications in those circumstances, but then really make sure it is cost sustainable going forward.”

The Alliance for Women’s Health and Prevention wrote a letter to Ayotte Tues

See Full Page